Posts
I’m more concerned about persistent inflation than deflation
Maybe I'm looking at this the wrong way, but I'm still a lot more worried about inflation than deflation. Every time I pay for insurance, healthcare, or anything housing-related, it feels like prices are still creeping higher. Even if the headline CPI keeps improving, it doesn't really feel that way …
Robinhood dashboard loss not matching up with actual amount lost?
Sorry - not able to post on the robinhood sub for some reason but maybe someone here can help. Let’s not look too much into wtf I’m doing yet bc idk but I’ve been using CashApp to trade here and there for the last few years and wanna get more …
Why do people say you cant beat the s&p when etfs like qqq and vgt have outperformed it for many years now?
So many financial channels say “just put ur money in s&p because you cant beat it” or s&p has beat every money manager” when its simply not true. Compare the returns of the s&p vs nasdaq the past 15 years and you’ll see nasdaq has blown s&p out the water
How do you day traders keep your wits with 24 hour trading?
I am not a day trader, but I am relatively active. I can go one week with 0 trades and then the next week do 40-50. I transitioned over to Schwab's Thinkorswim platform this summer and was happy to see I could trade at 4:00AM, but then I discovered you …
Rate my 30-year Core-Satellite portfolio
I’m 35 years old with a 30-year investment horizon. My goal is to maximize long-term returns while keeping the portfolio simple and disciplined. **Core (85%)** 55% S&P 500 UCITS ETF (Acc) 20% MSCI World ex-USA UCITS ETF (Acc) 10% Nasdaq 100 UCITS ETF (Acc) **Satellite (max 15%; 5-15%)** Individual stocks …
How often do you check your portfolio?
Just curious how often people check on their portfolio, or at least a watchlist of their stocks. I’m newer to investing, I have no intention to day trade or sell my stocks. I’m not worried about drops day to day. Everything I have is hold forever ETFs but I still …
Anyone else think Anthropic’s valuation is going to plummet?
I know this is probably an unpopular take, but I think the market is massively overestimating Anthropic’s moat. Bloomberg is reporting that DeepSeek is already preparing for an IPO after reportedly raising at around a $71B valuation, and they got there by showing you don’t necessarily need insane compute budgets …
AnaptysBio ($ANAB) - biotech with key upcoming price catalysts
AnaptysBio (ANAB) isn’t your traditional biotech play. Essentially, it is a low-overhead royalty-management company formed around 2 drugs: Jemperli (partnered with GSK) and imsidolimab (partnered with Vanda Pharma). Here’s the relevant backstory. In 2014, ANAB signed a collaboration and exclusive licensing agreement with the biotech company Tesaro, resulting in the …